Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children
Clinical trial NCT02153112 · COMPLETED
Trial details
- NCT number
- NCT02153112
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-23
- Primary completion
- 2018-06-20
- Enrollment
- 840
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.